The Latest From Celvionics

Celvionics Life Sciences Introduces Precision Immunology Development Strategy

Celvionics Advances CLV 101 Antibody Program for Autoimmune Disease

Celvionics Expands Rare Disease Research Platform

Celvionics Highlights Antibody Engineering Approach for Immune Pathway Targeting

Celvionics Builds Translational Framework for Targeted Biologic Therapies

Celvionics Announces Focus on Autoimmune and Inflammatory Disease Innovation

Precision Immunology: Building Therapeutics Around Disease Mechanism

Celvionics Pipeline Update: CLV 202 Enters Preclinical Research Focus

Celvionics Pipeline Update: CLV 303 Continues Discovery Work

Celvionics Outlines Collaboration Priorities in Advanced Biologic Therapies

Celvionics Life Sciences Launches Corporate Presence for Scientific Partnerships

Have a media or partnership inquiry?